8-K - Compass Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

by reference. Item 8.01. Other Events. On January 6, 2026, Compass Therapeutics, Inc. (the “Company”) issued a press release titled “Compass Therapeutics Provid

Financial Results

$209.0M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit 99.1 Press Release dated January 6, 2026 104 The cover page from this Current Report on Fo

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

PRESS RELEASE